Header Logo

Connection

Karen Wozniak to Mice

This is a "connection" page, showing publications Karen Wozniak has written about Mice.
Connection Strength

1.005
  1. Protective interaction of human phagocytic APC subsets with Cryptococcus neoformans induces genes associated with metabolism and antigen presentation. Front Immunol. 2022; 13:1054477.
    View in: PubMed
    Score: 0.107
  2. Transcriptional Changes in Pulmonary Phagocyte Subsets Dictate the Outcome Following Interaction With The Fungal Pathogen Cryptococcus neoformans. Front Immunol. 2021; 12:722500.
    View in: PubMed
    Score: 0.099
  3. Antifungal activity of dendritic cell lysosomal proteins against Cryptococcus neoformans. Sci Rep. 2021 06 30; 11(1):13619.
    View in: PubMed
    Score: 0.097
  4. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by ?d T cells. BMC Immunol. 2012 Dec 07; 13:65.
    View in: PubMed
    Score: 0.054
  5. Mechanisms of dendritic cell lysosomal killing of Cryptococcus. Sci Rep. 2012; 2:739.
    View in: PubMed
    Score: 0.053
  6. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. Clin Vaccine Immunol. 2011 May; 18(5):717-23.
    View in: PubMed
    Score: 0.048
  7. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One. 2011 Feb 17; 6(2):e17204.
    View in: PubMed
    Score: 0.048
  8. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One. 2009 Sep 03; 4(9):e6854.
    View in: PubMed
    Score: 0.043
  9. Isolation and purification of antigenic components of Cryptococcus. Methods Mol Biol. 2009; 470:71-83.
    View in: PubMed
    Score: 0.041
  10. Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect Immun. 2008 Oct; 76(10):4764-71.
    View in: PubMed
    Score: 0.040
  11. In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis. Infect Immun. 2006 Jul; 74(7):3817-24.
    View in: PubMed
    Score: 0.034
  12. Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis. Med Mycol. 2005 Nov; 43(7):589-601.
    View in: PubMed
    Score: 0.033
  13. Reduced estrogen signaling contributes to bone loss and cardiac dysfunction in interleukin-10 knockout mice. Physiol Rep. 2024 Jan; 12(1):e15914.
    View in: PubMed
    Score: 0.029
  14. Wheat Germ Supplementation Reduces Inflammation and Gut Epithelial Barrier Dysfunction in Female Interleukin-10 Knockout Mice Fed a Pro-Atherogenic Diet. J Nutr. 2023 03; 153(3):870-879.
    View in: PubMed
    Score: 0.027
  15. Candida-specific antibodies during experimental vaginal candidiasis in mice. Infect Immun. 2002 Oct; 70(10):5790-9.
    View in: PubMed
    Score: 0.027
  16. Borrelia peptidoglycan interacting Protein (BpiP) contributes to the fitness of Borrelia burgdorferi against host-derived factors and influences virulence in mouse models of Lyme disease. PLoS Pathog. 2021 04; 17(4):e1009535.
    View in: PubMed
    Score: 0.024
  17. IFN-? immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans. PLoS Pathog. 2018 10; 14(10):e1007358.
    View in: PubMed
    Score: 0.020
  18. Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection. PLoS One. 2017; 12(1):e0169347.
    View in: PubMed
    Score: 0.018
  19. Antifungal Activity of Plasmacytoid Dendritic Cells against Cryptococcus neoformans In Vitro Requires Expression of Dectin-3 (CLEC4D) and Reactive Oxygen Species. Infect Immun. 2016 09; 84(9):2493-504.
    View in: PubMed
    Score: 0.017
  20. Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection. Methods Mol Biol. 2016; 1403:551-66.
    View in: PubMed
    Score: 0.017
  21. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants. mBio. 2015 Oct 06; 6(5):e01433-15.
    View in: PubMed
    Score: 0.016
  22. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans. Infect Immun. 2015 Dec; 83(12):4513-27.
    View in: PubMed
    Score: 0.016
  23. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice. J Immunol. 2014 Oct 15; 193(8):4060-71.
    View in: PubMed
    Score: 0.015
  24. Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice. PLoS One. 2014; 9(8):e104316.
    View in: PubMed
    Score: 0.015
  25. The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway. PLoS One. 2012; 7(9):e46311.
    View in: PubMed
    Score: 0.013
  26. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation. J Immunol. 2012 Oct 15; 189(8):4060-8.
    View in: PubMed
    Score: 0.013
  27. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection. Infect Immun. 2010 Dec; 78(12):5341-51.
    View in: PubMed
    Score: 0.012
  28. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am J Pathol. 2010 Feb; 176(2):774-85.
    View in: PubMed
    Score: 0.011
  29. The role of Candida albicans NOT5 in virulence depends upon diverse host factors in vivo. Infect Immun. 2005 Nov; 73(11):7190-7.
    View in: PubMed
    Score: 0.008
  30. Contribution of cell surface hydrophobicity protein 1 (Csh1p) to virulence of hydrophobic Candida albicans serotype A cells. FEMS Microbiol Lett. 2005 Mar 15; 244(2):373-7.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.